Save time and get answers to complex questions with AI chat
Zemdri plazomicin nce gain exclusivity 2028 patent 2031?When will generic fiasap insulin be available?Dabrafenib patent expiration?Is it okay to take anti histamine when on statins?Drugpatentwatch trametinib?
See the DrugPatentWatch profile for vyvanse
Vyvanse (lisdexamfetamine dimesylate) was first approved by the U.S. Food and Drug Administration in 2007—specifically on March 22, 2007—as a prescription medication for treating attention‑deficit/hyperactivity disorder (ADHD).
Other Questions About Vyvanse :